KVUE · Full Picture

Kenvue Inc. — the full picture

Earnings window · 2026-07-16 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Segment Revenue Performance · Revenue growth & mixPriority 75
    +17.3% revenue (realized); 3 sources (news, press_release, sec_filing); structured_verified
    Fiscal six months Skin Health and Beauty Segment Net sales: $2,172 million, increase of $136 million, or 6.7%; excluding favorable FX of 2.3% Organic sales increased 4.4% (volume 2.6%, value realization 1.8%)
  2. Headcount / Restructuring · Restructuring & impairmentPriority 68
    -5.4% operating_income; 2 sources (news, press_release); 1 forward row(s); quote_verified
    The 2026 Restructuring Initiative is expected to result in pre-tax restructuring expenses and other charges totaling approximately $250 million in fiscal year 2026.
  3. Dividends · Buybacks & dividendsPriority 63
    2 sources (news, sec_filing); 1 forward row(s); quote_verified
    On July 29, 2026, we announced a 1.2% increase in the quarterly dividend as our Board declared a dividend of $0.21 per share payable on August 26, 2026 to shareholders of record as of the close of business on August 12, 2026.
  4. Kimberly-Clark Acquisition · M&A and divestituresPriority 61
    quote_verified
    Kenvue is undergoing a $40 billion buyout by Kimberly-Clark.
  5. Market Demand Trends · Demand, orders & backlogPriority 61
    3 sources (news, press_release, sec_filing); quote_verified
    Kenvue's second-quarter results showed 0.7% volume growth driving performance despite muted US and Europe performance, contributing to 3% revenue and 7% adjusted EPS growth per Morningstar.
  6. Liquidity and Debt Position · Debt, leverage & refinancingPriority 55
    -3.3% cash (realized); structured_verified
    Primary sources of liquidity include Cash and cash equivalents of $1,110 million as of June 28, 2026, borrowing capacity under a revolving credit facility of $4.0 billion which expires in March 2029, and authorized commercial paper program issuance of $4.0 billion.
  7. Segment Profitability · Operating income & profitabilityPriority 55
    +5.3% operating_income (realized); quote_verified
    Fiscal six months Skin Health and Beauty Segment adjusted operating income: $354 million, increased $113 million, or 46.9%
  8. Senior Notes Redemption · Debt, leverage & refinancingPriority 53
    -2.8% liability (realized); quote_verified
    On February 13, 2026, we issued a notice of full redemption to the holders of the 5.35% Senior Notes due 2026.
  9. Acquisition / Partnership / Divestiture · M&A and divestituresPriority 52
    +0.0% operating_income; 3 sources (news, press_release, sec_filing); 4 forward row(s); quote_verified
    The transaction with Kimberly-Clark is expected to close in the fourth quarter of 2026, subject to receipt of foreign regulatory approvals and satisfaction of other customary closing conditions.
  10. Restructuring and Supply Chain Transformation · Restructuring & impairmentPriority 50
    -1.1% operating_income; 3 forward row(s); quote_verified
    The 2026 Restructuring Initiative is expected to result in pre-tax restructuring expenses and other charges totaling approximately $250 million in fiscal year 2026.
  11. Liquidity and Debt Position · Liquidity & cash positionPriority 48
    quote_verified
    Net debt was $(7.4) billion as of June 28, 2026 and $(7.5) billion as of December 28, 2025 (Cash and cash equivalents $1.1B, Total debt $(8.5)B).
  12. Operating Expense Trends · Operating expenses (SG&A)Priority 48
    quote_verified
    Selling, general, and administrative expenses for the fiscal six months ended June 28, 2026: $2,990 million, a decrease of $51 million, or 1.7%; SG&A as a percentage of Net sales decreased 210 basis points to 38.0% from 40.1%

Threads by pillar

Revenue & Demand Priority 87 · 6 threads

Costs & Margins Priority 87 · 8 threads

Capital & Balance Sheet Priority 80 · 6 threads

Strategy & Portfolio Priority 68 · 2 threads

Legal, Regulatory & Policy Priority 46 · 2 threads

Guidance & Outlook Priority 38 · 1 thread

Macro & Market Conditions Priority 37 · 3 threads

Expected impact by metric

metricforward netforward grossrealized
operating_income-6.7%+15.4%+5.3%
cash——-3.6%
margin——+0.1%
revenue——+17.3%
liability——-2.8%